Polycom , the open standards-based unified communications and collaboration provider announced that Dr. Reddy’s Laboratories, a global pharmaceutical company, has selected Polycom immersive video collaboration solutions including the Polycom RealPresence Experience (RPX), to enable executives and employees across two major corporate offices in Hyderabad, India, and Bridgewater, New Jersey, USA to collaborate face-to-face via secure, high-definition video. The company’s smaller offices, manufacturing units, and research and development facilities dispersed across the globe will also benefit from the rollout of the video collaboration solutions.
Dr. Reddy’s has deployed several Polycom solutions to improve its business processes. This includes two Polycom RPX immersive telepresence solutions in its Hyderabad and Bridgewater, New Jersey corporate centres, fitted with document cameras to display samples of drugs and generics for real-time inspections with FDA officials, product reviews with co-workers, and sample showcases for buyers. To expedite senior level decision making between the US and India and to reduce the time and cost of frequent travel, the company also selected the Polycom RealPresence Immersive (RPX 200) series: a fully immersive video experience with an all-inclusive meeting space that brings HD video, audio, and content-sharing to a cinematic video wall. In addition, Dr. Reddy’s financial and marketing teams are also benefiting from video capabilities, for everything from joining the announcement of quarterly results to sharing market development information and product promotions.
Additionally, the implementation of Polycom RealPresence Mobile video solutions across iOS and Android smartphones and tablet devices has meant that senior level executives are able to join critical internal meetings from anywhere while on the move. The company has also deployed management suites monitoring and scheduling capabilities.
“Our company’s global demand for instant communication across distances, particularly between R&D teams to make decisions quickly, meant that we required more effective and efficient ways to collaborate. With Polycom video, we are getting the most comprehensive UC infrastructure that meets our needs to deliver wide-scale communications across the company, enabling our research and technical teams to meet across any distance and collaborate securely and instantly for vital consultation and decision-making,” said Atanu Roy, Chief Technical Officer, Dr. Reddy’s. “For our executive team in particular, video collaboration has enabled a new way of conducting business without the need for frequent travel across large distances. This in itself has not only helped us achieve significant savings in time and travel cost, but also establish a better work-life balance.”
Polycom teamed with HP to deliver a complete end-to-end video collaboration solution that satisfied Dr. Reddy’s requirements, working with a wide range of UC solutions, including Microsoft Lync, which the company looks to apply in future. With the combination of Lync and Polycom RealPresence solutions, employees will be able to launch video collaboration sessions easily and intuitively from within familiar interfaces and normal workflows, from any work environment on- or off-premises.
“For a company with widely-dispersed teams and in an industry that requires constant conferring, video collaboration is the anytime access solution for speedy decision-making and shortened time to market,” said Alok Anand, Head of Marketing, India & SAARC, Polycom. “With Polycom’s high-definition video collaboration and advanced content-sharing capabilities, the true-to-life immersive video collaboration makes all the difference in making team meetings highly effective.”
Dr. Reddy’s will look to implement additional immersive, room, and mobile video solutions across more locations to continue the transformation in team collaborations and create a new video work culture. Further, the company also plans to introduce video collaboration at manufacturing facilities, to enable R&D teams to liaise more quickly and efficiently in formulating new drugs and generics, and obtaining approvals from authorities.
